Resveratrol demonstration is related to huge market benefits

A study published in the journal Nature by scientists from Pfizer pharmaceutical company has caused a lot of controversy recently Resveratrol, once thought to be a beneficial substance in red wine, doesn't actually help people slow down aging directly, the study said Resveratrol was once thought to stimulate the synthesis of a particular protease, which would help slow down aging in humans As a result, the study says, those who are trying to extend their lives with red wine pills may be disappointed Scientists around the world expressed their different opinions after the report was published Some people think that resveratrol may not play a direct biochemical role, so it may not be able to find its effect through direct detection The scientists suggest that people can continue to take resveratrol and maintain the proper drinking habits In fact, the process of biochemical action is sometimes quite complex, not limited to the direct action of one chemical substance with another Some scientists suggest that when people plan to take resveratrol, they should first control the dosage High dose administration may have side effects; on the other hand, it is necessary to ensure the purity of resveratrol Typically, a glass of five ounce red wine contains 60 mg of resveratrol Resveratrol is found in the skin of the red article: winechina.com grape It is said that resveratrol can prevent cells from aging by stimulating protease The earliest study was based on the French population statistics, and the incidence rate of heart disease in this high-fat eating habit was surprisingly low Pfizer's report said that the protease can indeed delay cell aging, and has therapeutic effects on type 2 diabetes The problem is that resveratrol does not seem to regulate the biochemical effects of the protease, especially at low doses At the end of the day, the debate is actually about huge business interests In a Harvard report, a new drug based on resveratrol from Sirtris Pharmaceutical Co was approved The pharmaceutical company was subsequently acquired by GlaxoSmithKline for $720 million The company is testing three new drugs, all of which use proteins to fight cancer and diabetes A spokesman for GlaxoSmithKline said Pfizer's research method is strange, they just want to prove that resveratrol is not good for human body! At present, there are many resveratrol skins on sale in the U.S market, and the cheapest price is only $5 to get a month's treatment dosage Of course, no pill can replace wine, which brings romance and pleasure to people!